<DOC>
	<DOCNO>NCT00809536</DOCNO>
	<brief_summary>1 . To estimate effect multiple dos PD 0332334 elimination single dose metformin body 2 . To estimate effect multiple dos metformin elimination single dose PD 0332334 body 3 . To evaluate safety tolerability PD 0332334 metformin administer time .</brief_summary>
	<brief_title>Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time</brief_title>
	<detailed_description>Detailed Description : Additional Study Purpose Details : To assess pharmacokinetics metformin PD 0332334 concurrent administration . On February 18th 2009 , decision terminate development PD 0332334 communicate investigator study . The decision terminate study base safety concern .</detailed_description>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Nonsmokers Male female adult Current history significant medical illness Smokers Illicit drug use</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>metformin , PD 0332334 , organic cation transporter , OCT2 , pharmacokinetics</keyword>
</DOC>